Showing results (1-10 of 86) with videos related to
Sort By:
Pageof 9
Oncoimmunology|July 30, 2013
A self antigen reopens the games in pancreatic cancerPaola Cappello, Francesco NovelliJournal of Immunotherapy (Hagerstown, Md. : 1997)|April 2, 2002
Death receptor ligands in tumorsPaola Cappello, Francesco Novelli, Guido Forni, et al.Methods in Molecular Biology (Clifton, N.J.)|January 7, 2022
Discovery of Targets for Cancer ImmunopreventionPaola Cappello, Sara Bulfamante, Giorgia Mandili, et al.Frontiers in Bioscience (Landmark Edition)|November 5, 2016
Alpha-Enolase (<i>ENO1</i>), a potential target in novel immunotherapiesPaola Cappello, Moitza Principe, Sara Bulfamante, et al.Cancers|January 8, 2023
Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology TherapiesAnurag Kumar Srivastava, Giorgia Guadagnin, Paola Cappello, et al.The FEBS Journal|January 26, 2011
α-Enolase: a promising therapeutic and diagnostic tumor targetMichela Capello, Sammy Ferri-Borgogno, Paola Cappello, et al.Experimental Hematology & Oncology|April 19, 2013
Three are better than one: plasminogen receptors as cancer theranostic targetsPatrizia Ceruti, Moitza Principe, Michela Capello, et al.Cancers|February 22, 2018
Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo PartnersPaola Cappello, Claudia Curcio, Giorgia Mandili, et al.Antioxidants (Basel, Switzerland)|April 3, 2021
IL17A Depletion Affects the Metabolism of Macrophages Treated with GemcitabineCecilia Roux, Gianluca Mucciolo, Joanna Kopecka, et al.Oncoimmunology|July 29, 2016
Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell responsePaola Cappello, Elisabetta Tonoli, Roberta Curto, et al.Pageof 9